Next Article in Journal
Synergistic Effects of Curcumin and Antibiotics Against Drug-Sensitive and Multidrug-Resistant Mycobacterium tuberculosis
Previous Article in Journal
CD5 Expression in CTCL and Its Implications for Anti-CD5 CAR T-Cell Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kim et al. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062

1
Department of Tumor Biology, Graduate School of Medicine, Seoul National University, Seoul 03080, Republic of Korea
2
Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul 03080, Republic of Korea
3
Medical Science Research Institute, Seoul National University Bundang Hospital, Seongnam-si 13620, Republic of Korea
4
Department of Radiation Oncology, Seoul National University Bundang Hospital, 173 Gumiro, Seongnam-si 13620, Republic of Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2025, 26(21), 10413; https://doi.org/10.3390/ijms262110413
Submission received: 27 August 2025 / Accepted: 2 September 2025 / Published: 27 October 2025
(This article belongs to the Section Molecular Oncology)
In the original publication [1], there was a mistake in the left graph of Figure 5L as published. We inadvertently duplicated the graph for PMN-MDSCs and used it in place of the graph intended to represent M-MDSCs. As a result, both graphs in Figure 5L displayed the same PMN-MDSC data, and the actual M-MDSC data was omitted.
The corrected Figure 5L appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Kim, S.; Jeon, S.H.; Han, M.G.; Kang, M.H.; Kim, I.A. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062. [Google Scholar] [CrossRef] [PubMed]
Figure 5. Changes in tumor-infiltrating immune cells by RT and BRD4 inhibition. (A,B) Representative IHC images (A) and relative expression (B) of CD68 in tumors. (C,D) Representative flow cytometry plots (C) and frequencies (D) of M1 and M2 tumor-associated macrophages (TAMs) in tumors. (E,F) Representative flow cytometry plots (E) and frequencies (F) of CD8+ T cells and CD4+ T cells in tumors. (G,H) Representative IHC images (G) and relative expression (H) of CD8 in the TME. (I,J) Representative flow cytometry plots (I) and frequencies (J) of regulatory T cells (Tregs) in tumors. (K,L) Representative flow cytometry plots (K) and frequencies (L) of monocytic and polymorphonuclear myeloid-derived suppressor cells (MDSCs) in tumors. (***) p < 0.001; (**) p < 0.01; (*) p < 0.05.
Figure 5. Changes in tumor-infiltrating immune cells by RT and BRD4 inhibition. (A,B) Representative IHC images (A) and relative expression (B) of CD68 in tumors. (C,D) Representative flow cytometry plots (C) and frequencies (D) of M1 and M2 tumor-associated macrophages (TAMs) in tumors. (E,F) Representative flow cytometry plots (E) and frequencies (F) of CD8+ T cells and CD4+ T cells in tumors. (G,H) Representative IHC images (G) and relative expression (H) of CD8 in the TME. (I,J) Representative flow cytometry plots (I) and frequencies (J) of regulatory T cells (Tregs) in tumors. (K,L) Representative flow cytometry plots (K) and frequencies (L) of monocytic and polymorphonuclear myeloid-derived suppressor cells (MDSCs) in tumors. (***) p < 0.001; (**) p < 0.01; (*) p < 0.05.
Ijms 26 10413 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kim, S.; Jeon, S.H.; Han, M.G.; Kang, M.H.; Kim, I.A. Correction: Kim et al. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062. Int. J. Mol. Sci. 2025, 26, 10413. https://doi.org/10.3390/ijms262110413

AMA Style

Kim S, Jeon SH, Han MG, Kang MH, Kim IA. Correction: Kim et al. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062. International Journal of Molecular Sciences. 2025; 26(21):10413. https://doi.org/10.3390/ijms262110413

Chicago/Turabian Style

Kim, Seongmin, Seung Hyuck Jeon, Min Guk Han, Mi Hyun Kang, and In Ah Kim. 2025. "Correction: Kim et al. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062" International Journal of Molecular Sciences 26, no. 21: 10413. https://doi.org/10.3390/ijms262110413

APA Style

Kim, S., Jeon, S. H., Han, M. G., Kang, M. H., & Kim, I. A. (2025). Correction: Kim et al. BRD4 Inhibition Enhances the Antitumor Effects of Radiation Therapy in a Murine Breast Cancer Model. Int. J. Mol. Sci. 2023, 24, 13062. International Journal of Molecular Sciences, 26(21), 10413. https://doi.org/10.3390/ijms262110413

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop